Validación del modelo de predicción de mortalidad ISARIC 4C para SARS-CoV-2 en Hospital Universitario Cruces

  1. Martínez-Ruiz, Alberto 123
  2. Jimeno-Rodríguez, Aitor-Ignacio 2
  3. Maroño-Boedo, María-Jesús 3
  4. Guereca-Gala, Ane 3
  5. Olabarrieta, Unai 3
  6. Bergese, Sergio D. 4
  1. 1 Instituto de Investigación Sanitaria Biocruces Bizkaia
    info

    Instituto de Investigación Sanitaria Biocruces Bizkaia

    Barakaldo, España

    ROR https://ror.org/0061s4v88

  2. 2 Universidad del País Vasco/Euskal Herriko Unibertsitatea
    info

    Universidad del País Vasco/Euskal Herriko Unibertsitatea

    Lejona, España

    ROR https://ror.org/000xsnr85

  3. 3 Servicio Vasco de Salud-Osakidetza. Organización Sanitaria Integrada Ezkerraldea-Enkarterri-Cruces. Hospital Universitario Cruces. Servicio de Anestesia, Reanimación y Terapia del Dolor. Barakaldo, España
  4. 4 Universidad de Stony Brook. Departamento de Anestesiología. New York, Estados Unidos
Show affiliations +
Journal:
Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios

ISSN: 0304-4858,  2173-2302

Year of publication: 2022

Volume: 119

Issue: 1

Pages: 12-19

Type: Article

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios

Abstract

Objective: To validate a mortality prediction model called ISARIC 4C in a sample of patients of patients admitted to the Hospital de Cruces between March 12, 2020 and May 16, 2020 with the diagnosis of pneumonia due to SARS-CoV-2Material and method:Cohort study, observational and single-center, which included patients admitted to hospital with suspected COVID-19 pneumonia. Data of the patients at admission: age, gender, existence and number have been analyzed. of comorbidities, in addition to analytical data such as respiratory rate, oxygen saturation, Glasgow scale, urea level and C-reactive protein level.Results:The ISARIC 4C model is not valid to the sample of our patients.Conclusions:Given the magnitude of the COVID-19 pandemic, more studies are needed to validate a mortality prediction model applicable to the entire population.

Bibliographic References

  • Isaza-Jaramillo S, Jaimes-Barragán F. Ronda clínica y epidemiológica: aproximación a los modelos de predicción clínica. Iatreia. 2017; 30:92-99.
  • Donado JH, Higuita-Duque LN, Castro-Palacio JJ. Modelos de predicción de riesgo cardiovascular. Med U.P.B. 2017;36(2):153-160.
  • Plan de contingencia de uci-cuidados críticos en Osakidetza para hacer frente a la pandemia por el virus SARS-CoV-2. Dirección general de Osakidetza 25 de abril de 2020.
  • Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020 Sep 9;370:m3339.
  • Berenguer J, Borobia AM, Ryan P, et al. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID- 19: the COVID-19 SEIMC score. Thorax 2021;0:1–10.
  • Covino M, De Matteis G, Burzo ML, Russo A, Forte E, Carnicelli A et al; GEMELLI AGAINST COVID-19 Group. Predicting In-Hospital Mortality in COVID- 19 Older Patients with Specifically Developed Scores. J Am Geriatr SOc. 2021 Jan; 69(1):37- 41.
Data source: Dialnet